dpp 4 inhibitors vs glp 1 GLP-1-RA and DPP-4 in the management of type 2 diabetes fig2.gif

This temporary heightened appetite typically normalizes over 4-8 weeks as your hormonal system restabilizes

It's the first step in your SkinFitness journey, and there's absolutely no pressure to commit

Hair Loss and GLP-1 Agonists

Many patients experience: reduced appetite improved portion control steady weight loss progressions Tirzepatide Tirzepatide activates two metabolic pathways (GLP-1 and GIP) involved in appetite and energy regulation. This dual-action approach can support: stronger appetite regulation improved metabolic response meaningful weight loss outcomes for some patients Your Weight Loss Journey At Glow Lab, GLP-1 treatments are delivered through guided medical care and ongoing support

Our findings are directly consistent with prior reports in advanced CKD and ESRD populations